• 65 Hits
  • Search Condition : Filter (MeSH = Stomach Neoplasms / drug therapy*)
Species Resource Title
Human and Animal Cells MKN45(RCB1001) , MKN74(RCB1002) , Kato III(RCB2088) Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.
Pathogenic eukaryotic microorganisms Streptomyces sp. IFM 11490 Elmenols C-H, new angucycline derivatives isolated from a culture of Streptomyces sp. IFM 11490.
Human and Animal Cells MKN1(RCB1003) Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
Human and Animal Cells MKN74(RCB1002) , Kato III(RCB2088) Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
Human and Animal Cells MKN45(RCB1001) Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer.
Human and Animal Cells MKN45(RCB1001) , MKN74(RCB1002) , MKN7(RCB0999) , HuG1-N(RCB1179) Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer.
Human and Animal Cells MKN45(RCB1001) Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
Human and Animal Cells MKN45(RCB1001) STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells.
Human and Animal Cells MKN74(RCB1002) Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis.
Human and Animal Cells NUGC-4(RCB1939) , HL60(RCB0041) Combined treatment with dissolved hydrogen molecule and platinum nanocolloid exerts carcinostatic/carcinocidal effects by increasing hydrogen peroxide generation and cell death in the human gastric cancer cell line NUGC-4.
Human and Animal Cells MKN1(RCB1003) (S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.
Human and Animal Cells MKN45(RCB1001) Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model.
Human and Animal Cells Kato III(RCB2088) , MKN1(RCB1003) , MKN45(RCB1001) , MKN74(RCB1002) , GCIY(RCB0555) , NUGC-4(RCB1939) Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer.
Human and Animal Cells MKN45(RCB1001) Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
Human and Animal Cells MKN1(RCB1003) , MKN45(RCB1001) Targeting IRF3 as a YAP agonist therapy against gastric cancer.
Human and Animal Cells L929 Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen.
Human and Animal Cells HGC-27(RCB0500) , GT3TKB(RCB0885) In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours.
Human and Animal Cells MKN45(RCB1001) , MKN74(RCB1002) Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin.
Human and Animal Cells MKN45(RCB1001) Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.
Human and Animal Cells MKN45(RCB1001) Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4′-piperidine]-2-ones as potential c-Met inhibitors